Asunto(s)
Carcinoma de Células Renales/etiología , Enfermedades Renales Quísticas/etiología , Fallo Renal Crónico/complicaciones , Neoplasias Renales/etiología , Biomarcadores de Tumor/análisis , Biopsia , Carcinoma de Células Renales/química , Carcinoma de Células Renales/patología , Carcinoma de Células Renales/cirugía , Humanos , Inmunohistoquímica , Queratina-7/análisis , Enfermedades Renales Quísticas/metabolismo , Enfermedades Renales Quísticas/patología , Enfermedades Renales Quísticas/cirugía , Fallo Renal Crónico/diagnóstico , Fallo Renal Crónico/terapia , Neoplasias Renales/química , Neoplasias Renales/patología , Neoplasias Renales/cirugía , Masculino , Persona de Mediana Edad , Nefrectomía , Racemasas y Epimerasas/análisis , Diálisis RenalAsunto(s)
Colágeno Tipo III/análisis , Enfermedades Renales/diagnóstico , Glomérulos Renales/química , Anciano , Biomarcadores/análisis , Biopsia , Colágeno Tipo III/ultraestructura , Fibrosis , Humanos , Enfermedades Renales/metabolismo , Enfermedades Renales/patología , Glomérulos Renales/ultraestructura , Masculino , Microscopía Electrónica , PronósticoRESUMEN
BACKGROUND: Interstitial inflammation (i-INT) is the driver of T-cell-mediated rejection. Its causes, pathophysiology, kinetics, and outcomes are poorly documented. METHODS: The role of i-INT was evaluated in 2055 biopsies from 775 renal transplant recipients. RESULTS: i-INT was present in 374 (18.2% prevalence) from acute and subclinical rejection (67.4%); interstitial fibrosis and tubular atrophy (14.4%); BK virus nephropathy (BKVAN) 9.9%; and acute tubular necrosis (ATN with i-INT) in 5.9% of cases. i-INT was predicted by prior T-cell-mediated rejection and BKVAN, human leukocyte antigen mismatch, cyclosporine therapy, and indication biopsy for dysfunction. It correlated with tubulitis, arteritis, and antibody markers within concurrent histology (P < 0.001). After treatment, renal functional recovery was best with histological ATN, milder i-INT, and early posttransplant biopsy times. The initial histological improvement of inflammation depended on baseline i-INT severity. Complete resolution to Banff i0 was predicted by early biopsy time, antilymphocyte therapy, recipient age, and medication compliance (all P < 0.001). Clearance i-INT was followed by delayed resolution of tubulitis (P < 0.001). i-INT was associated with histological ATN, renal dysfunction, and increased incident fibrosis on sequential pathology. Progressive fibrosis following related-rejection i-INT was dependent on tubulitis using multivariable analysis. In contrast, fibrogenesis after BKVAN or ATN was unrelated to inflammation. i-INT cases were followed by recurrent rejection in 35.3%, increased graft loss, and greater patient mortality. Multiple complementary outcome analyses determined the optimal lower diagnostic threshold for inflammation was Banff i1 score. CONCLUSIONS: i-INT is a heterogeneous pathological phenotype that results in adverse functional and structural outcomes, for which active and robust therapy should be considered.
Asunto(s)
Rechazo de Injerto/patología , Trasplante de Riñón/efectos adversos , Riñón/patología , Nefritis/patología , Adulto , Atrofia , Biopsia , Femenino , Fibrosis , Rechazo de Injerto/tratamiento farmacológico , Rechazo de Injerto/inmunología , Rechazo de Injerto/fisiopatología , Supervivencia de Injerto , Humanos , Inmunidad Celular , Inmunosupresores/uso terapéutico , Riñón/efectos de los fármacos , Riñón/inmunología , Riñón/fisiopatología , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Nefritis/tratamiento farmacológico , Nefritis/inmunología , Nefritis/fisiopatología , Fenotipo , Valor Predictivo de las Pruebas , Medición de Riesgo , Factores de Riesgo , Linfocitos T/inmunología , Factores de Tiempo , Resultado del TratamientoRESUMEN
INTRODUCTION: Angiomyofibroblastoma (AMFB) is a rare, benign, mesenchymal cell tumour which presents as a slow-growing mass. It is most commonly seen in the vulva and is often mistaken for Bartholin's abscess. It is histologically diagnosed by the presence of stromal cells intermingled with small blood vessels. It is morphologically similar to cellular angiofibroma and aggressive angiomyxoma, the latter of which is locally invasive and has a possibility of metastasis and a high risk of local recurrence. There is one reported case of an AMFB undergoing sarcomatous transformation. CASE REPORT: We report a case of a multiparous, 36-year-old woman with an anterior vaginal mass which was inappropriately treated as a vaginal prolapse prior to definitive surgical management. This is only the second reported case of an AMFB presenting as a prolapsing mass.
Asunto(s)
Histiocitoma Fibroso Maligno/patología , Neoplasias Cutáneas/patología , Actinas/metabolismo , Adolescente , Antígenos CD/metabolismo , Antígenos de Diferenciación Mielomonocítica/metabolismo , Brazo , Cejas , Histiocitoma Fibroso Maligno/metabolismo , Histiocitoma Fibroso Maligno/secundario , Humanos , Masculino , Recurrencia Local de Neoplasia/patología , Neoplasias Cutáneas/metabolismo , Adulto JovenRESUMEN
AIM: To report a case of metastatic small-cell neuroendocrine carcinoma presenting as an isolated choroidal mass and initially misdiagnosed as a circumscribed choroidal hemangioma. METHODS: The clinical history, fundus findings, imaging, cytology and immunohistochemical features are described. RESULTS: An otherwise healthy 66-year-old man was referred for a left nasal scotoma and a diagnosis of circumscribed choroidal hemangioma. Cytology showed cohesive clusters of small-to-intermediate malignant cells. The atypical cells stained positively for chromogranin, thyroid transcription factor-1 and synaptophysin consistent with small-cell neuroendocrine carcinoma. CONCLUSION: Small-cell neuroendocrine carcinoma metastatic to the choroid is extremely rare; however, it is particularly aggressive and should be included in the differential diagnosis of isolated choroidal lesions, even in otherwise healthy patients.
RESUMEN
Benign vascular lesions have a diverse appearance and can be extremely difficult to classify. We present renal anastomosing hemangiomas from 2 patients that exemplify the potential diverse range of appearances that can occur in this recently described, rare variant of capillary hemangioma. The lesion from one patient was an intravenous hemangioma with closely packed, fenestrated vascular channels that were reminiscent of the splenic red pulp. Also, the endothelial cells contained hyaline globules. On the other hand, the second patient had multifocal tumor. The lesions showed more extensive hyalinization and vascular ectasia reminiscent of cavernous hemangioma. Extramedullary hematopoiesis was a feature in all the tumors, particularly in the second patient where numerous immature blasts were present within vascular spaces.
Asunto(s)
Hemangioma/patología , Neoplasias Renales/patología , Femenino , Hemangioma/complicaciones , Humanos , Fallo Renal Crónico/complicaciones , Neoplasias Renales/complicaciones , Trasplante de Riñón , Masculino , Persona de Mediana EdadRESUMEN
Plexiform fibrohistiocytic tumor is a rare soft tissue tumor that has a propensity to occur in the extremities in adolescents and young adults. Its cytologic features are not well documented, with only two case reports available in the literature. We present the case of a recurrent plexiform fibrohistiocytic tumor in a 19-year-old male, the cytologic features of which mimic that of a high-grade sarcoma. We discuss the likely differential diagnosis based on the cytologic findings and a review of the current literature on this highly unusual tumor is also performed.